Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/01/049279
CTRI/2023/01/049279
Not Yet Recruiting
Phase 2

Comparison of bone density and implant stability between osseodensification and conventional drilling technique â?? A split mouth randomised Controlled Trial.

A R Sanofar0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
A R Sanofar
Status
Not Yet Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
A R Sanofar

Eligibility Criteria

Inclusion Criteria

  • •1\. Adequate bone height and width after extraction to accommodate the implant without impinging on vital structures in either maxillary or
  • •mandibular arches.
  • •2\. Bone density range between \<\=850 and \>\=150 measured in Hounsefield units based on CBCT findings (corresponding to D3 \-D4 bone density according to bone density classification by Misch).
  • •3\. Medically fit participants of age range between 24 â?? 50 years.
  • •4\. Willingness to participate for the duration of the study.
  • •5\. General good health
  • •6\. Patient who will give positive informed consent.
  • •7\. Both the edentulous areas having antagonist teeth.

Exclusion Criteria

  • •1\. High bone density (more than 850 HU corresponding to D1and D2 level of bone density classification by Misch),
  • •2\. Bone metabolic disorders such as osteoporosis, osteomalacia, rickets affecting surrounding bone health.
  • •3\. History of radiotherapy in head and neck region.
  • •4\. Current habit of smoking or alcohol or drug abuse.
  • •5\. Systemic conditions as uncontrolled diabetic and hypertensive patients and cardiovascular conditions affecting the integrity of implant or
  • •connective tissue health surrounding the implant.
  • •6\. Bleeding dyscrasias or under anticoagulant therapy.
  • •7\. Needed augmentation of the implant site.
  • •8\. Signs of infection in the prospective implant site.
  • •9\. History of participants undertaking

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
By checking stability of implant and bone density around implant this study will be comparing two growth factors namely concentrated growth factor and injectable platelet rich fibrin when mixed with bone graft and used in maxillary sinus floor lifting procedure during implant surgery
CTRI/2023/08/057033Dr Unnati Agarwal10
Not Yet Recruiting
Phase 2
A clinical study to evaluate the marginal bone loss and implant stability by placing immediate and delayed implants in mandibular posterior region.
CTRI/2021/08/035677chinta Anand
Not Yet Recruiting
Phase 2
Effect of 1% Metformin gel on bone density.
CTRI/2024/05/067922Dr Tushar Mohata
Not Yet Recruiting
Phase 3
Bone performance of ultraviolet light activated dental implants used for overdentures in patient with moderately controlled diabetesHealth Condition 1: K081- Complete loss of teeth
CTRI/2024/07/069739Dr Harshal Jain
Unknown
N/A
Correlation Between Radiographic Bone Density in CBCT and Implant Stability Quotient Value: Clinical Observational StudyDental Implantation
NCT03164759Cairo University35